CIK: 1214127 - Address: C/O Alector, Inc., 131 Oyster Point Blvd., Suite 600, South San Francisco, CA 94080
16 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg
S%ret113053454911
S%wins673333330028

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
2/24/14 19:59
2/21/14
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsLavigne Louis J JrCADS-679125.7933-5-2418I263161643621161481-1-7-5232
2/13/14 17:59
2/11/14
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsLavigne Louis J JrCADS.d-6,683122.3933-55-7023D226121411913441015128847
8/30/12 20:19
8/29/12
AGNAllergan IncDEHealthDrugPharmaceutical PreparationsLavigne Louis J JrCADS-1,27685.0433-15-4320I91223715744-10248667
12/6/04 18:10
12/2/04
DNAGenentech IncDEHealthDrugPharmaceutical PreparationsLavigne Louis J JrCAOEVP,CFOS.d-3,81850.910-75-926D
11/9/04 20:06
11/5/04
DNAGenentech IncDEHealthDrugPharmaceutical PreparationsLavigne Louis J JrCAOEVP,CFOS.d-6,91950.500-137-966D
11/9/04 20:05
11/5/04
DNAGenentech IncDEHealthDrugPharmaceutical PreparationsLavigne Louis J JrCAOEVP,CFOS-6,92750.200-138-1000D
4/26/04 18:30
4/22/04
DNAGenentech IncDEHealthDrugPharmaceutical PreparationsLavigne Louis J JrCAOEVP,CFOS.d-5,926118.520-50-943D
2/5/04 18:57
2/3/04
DNAGenentech IncDEHealthDrugPharmaceutical PreparationsLavigne Louis J JrCAOEVP,CFOS.d-1,19196.810-12-803D
2/5/04 18:56
2/3/04
DNAGenentech IncDEHealthDrugPharmaceutical PreparationsLavigne Louis J JrCAOEVP,CFOS-3,64296.600-38-990D
1/27/04 18:25
1/23/04
DNAGenentech IncDEHealthDrugPharmaceutical PreparationsLavigne Louis J JrCAOEVP,CFOS.d-1,76996.650-18-873D
1/27/04 18:24
1/23/04
DNAGenentech IncDEHealthDrugPharmaceutical PreparationsLavigne Louis J JrCAOEVP,CFOS-3,43596.480-36-1000D
1/27/04 18:24
1/23/04
DNAGenentech IncDEHealthDrugPharmaceutical PreparationsLavigne Louis J JrCAOEVP,CFOS-6,30396.230-66-1000D
1/27/04 18:23
1/23/04
DNAGenentech IncDEHealthDrugPharmaceutical PreparationsLavigne Louis J JrCAOEVP,CFOS-2,93896.030-31-1000D
7/29/03 20:07
7/25/03
DNAGenentech IncDEHealthDrugPharmaceutical PreparationsLavigne Louis J JrCAOEVP,CFOS.d-42779.070-5-663D
7/29/03 18:27
7/25/03
DNAGenentech IncDEHealthDrugPharmaceutical PreparationsLavigne Louis J JrCAOEVP,CFOS.d-2,43278.720-31-923D
7/28/03 20:38
7/24/03
DNAGenentech IncDEHealthDrugPharmaceutical PreparationsLavigne Louis J JrCAOEVP,CFOS.d-3,47479.490-44-943D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact